 |
|
|
| |
Add-on Peginterferon Alfa-2a significantly reduces HBsAg levels in HBeAg-negative, genotype D chronic hepatitis B patients fully suppressed on nucleot(s)ide analogue treatment The HERMES Study
|
| |
| |
Reported by Jules Levin
EASL 2015 April 22-26 Vienna Austria
Pietro Lampertico1, Maurizia R. Brunetto2, Antonio Craxì3, Giovanni B. Gaeta4, Mario Rizzetto5, Giulio Palmieri6, Massimo Colombo1 on behalf of the HERMES Study Team
1Division of Gastroenterology and Hepatology, Ospedale Maggiore Policlinico, University of Milan, Italy
2Liver Unit, Reference Centre for Chronic Liver Disease and HCC of the Tuscany Region, University Hospital of Pisa, Italy;
3Gastroenterology and Hepatology, Di.Bi.M.I.S., University of Palermo, Italy;
4Department of Internal Medicine, Section of Infectious Disease, Second University of Naples, Italy;
5Department of Gastroenterology, University of Turin, Italy;
6Roche S.p.A., Monza, Italy
|
| |
|
|
|
|
|
